Psychiatric & Mental Illness CME Courses

myCME/CE

Psychiatry CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Bipolar Disorder Across the Lifecycle

Bipolar Disorder Across the Lifecycle | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
Bipolar disorder is often missed by clinicians in practice.Moreover non evidence based treatments are used commonly for this disorder. This program will address the evidence based treatments for bipolar disorder including the role for antidepressants.
Innovations in Managing Insomnia Across the Lifecycle

Innovations in Managing Insomnia Across the Lifecycle | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
The talk will discuss the differential diagnosis of insomnia in psychiatric patients, and how to apply evidence-based pharmacotherapies for insomnia. The role of non-pharmacological approaches for insomnia will also be discussed.
Management of Narcolepsy and Sleep Apnea in Psychiatric Patients

Management of Narcolepsy and Sleep Apnea in Psychiatric Patients | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
The talk will discuss the differential diagnosis of narcolepsy and sleep apnea in psychiatric patients, and how to apply evidence-based pharmacotherapies for narcolepsy and sleep apnea. The role of non-pharmacological approaches for narcolepsy and sleep apnea will also be discussed.
Recent Advances in Treating Schizophrenia

Recent Advances in Treating Schizophrenia | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
There are many unmet needs in the treatment of schizophrenia. This program will address innovative approaches to treat positive, negative, and cognitive symptoms of schizophrenia.
Tardive Dyskinesia – A Primer for Clinicians

Tardive Dyskinesia – A Primer for Clinicians | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
Tardive dyskinesia is a not uncommon long term, potentially irreversible side effect of antipsychotics. This program will discuss the prevalence, differential diagnosis and evidence based treatments for TD including FDA approved treatments.
Tardive Dyskinesia Across Psychiatric Disorders

Tardive Dyskinesia Across Psychiatric Disorders | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
This program, which features John Miller, MD and Rebecca Roma, MD, will address the diagnostic issues and differential diagnosis of patients with TD across psychiatric illnesses. The importance of the AIMS examination and evidence-based treatments for TD will be discussed.
Tardive Dyskinesia and Affective Disorders: Nuances in the 21st Century?

Tardive Dyskinesia and Affective Disorders: Nuances in the 21st Century?

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
Tardive dyskinesia is a not uncommon long term, potentially irreversible side effect of antipsychotics. This program will discuss the prevalence in mood disorders, differential diagnosis and evidence based treatments for TD including FDA approved treatments.
Pharmacotherapy of Antipsychotic Induced Movement Disorders

Pharmacotherapy of Antipsychotic Induced Movement Disorders

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
Movement disorders are a not uncommon long term, potentially irreversible side effect of antipsychotics. This program will discuss the prevalence, differential diagnosis and evidence based treatments for these movement disorders, including FDA approved treatments.

Click for More Psychiatry Courses

Next hm-section-front in Psychiatry CME Courses